This site is intended for health professionals only

Home / News / Supply of epilepsy drug disrupted until May

Supply of epilepsy drug disrupted until May


By Beth Kennedy
Editor-in-chief

10 Jan 2020

The manufacturer Accord will be out of stock of the anti-epileptic drug Phenytoin Sodium NRIM 100mg capsules until ‘early May’.

The Department of Health and Social Care issued a supply disruption alert today (10 January), which contains advice on how to manage patients affected by the shortage.

The Pharmaceutical Services Negotiating Committee noted that as phenytoin is a category 1 anti-epileptic drug, it is recommended that patients are kept of a specific manufacturer’s product.

The negotiator noted that an alternative phenytoin sodium 100mg capsules manufactured by Flynn Pharma is available but warned that ‘switching to an alternative formulation requires monitoring and may also require specialist support, advice or referral’.


Want news like this straight to your inbox?


Latest News

Plan B
Government must consider ‘sensible measures’ to protect pharmacy teams this winter, RPS says
The Royal Pharmaceutical Society (RPS) is calling on the Government to implement ‘sensible measures’ to...
antiviral drugs
Covid antiviral drugs could be prescribed to prevent hospital admission ‘this winter’
The Government has made deals for hundreds of thousands of doses of two new antiviral...
Chronic fatigue
NICE to publish chronic fatigue guideline after final meeting next week
NICE will publish its long-anticipated updated guideline for myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS)...